A study lead by researchers from Mayo Clinic suggests remission from Crohn’s disease may be more likely if patients receive biologic therapy combined with immune-suppressing drugs first instead of ...

Rochester, Minn. -- Mayo Clinic researchers have found that Certolizumab pegol is an effective treatment for adults with Crohn’s disease, according to two new studies. These findings were published in ...

Inflammatory bowel disease (IBD) is a chronic inflammation of the digestive tract. It includes conditions such as ulcerative colitis and Crohn's disease. People with IBD may experience persistent ...

ROCHESTER, Minnesota — Inflammatory bowel disease, or IBD, is an umbrella term for a group of chronic conditions that cause inflammation and swelling in the digestive tract. It primarily includes two ...

Bhat: From a medication standpoint, there is still much to uncover regarding why treatments vary in effectiveness among individuals with Crohn’s disease. Overcoming the “ceiling effect” in current ...

Stelara is a biologic medicine used to treat moderate to severe Crohn’s disease and ulcerative colitis. Crohn’s disease and ulcerative colitis are inflammatory bowel diseases that cause inflammation ...

SAN DIEGO — Crohn’s disease (CD) has become more common in the United States, and an estimated 1 million Americans have the condition. Still, much is unknown about how to evaluate the individual risk ...

Bhat: I appreciate the growing emphasis on incorporating patient quality-of-life assessments into clinical trials and practice, given the significant impact of this disease. Continuously integrating ...